| Israele | Turchia | Austria | |
| Nefrectomia | da $22,500 | da $10,000 | da $22,000 |
| Chirurgia conservativa del rene | da $19,000 | da $13,480 | da $20,000 |
| Nefrectomia con Robot Da Vinci | - | da $10,000 | da $16,000 |
Giorno 1
Giorno 2
Giorno 3
Giorno 4
Giorni 5-7
Settimana 2
Settimane 3-4
Settimane 5-6
Settimane 7-8
Si prega di notare che la cronologia di recupero di ciascun paziente può variare a seconda delle condizioni di salute individuali e della complessità della procedura chirurgica.
Capo dell'Unità di Oncologia dei Tessuti Molli e delle Ossa presso il Sourasky Medical Center – Il Prof. Merimsky è specializzato in casi complessi di sarcoma.
Dr. Ofer Yossefovitz is a leading Israeli urological surgeon. He specializes in oncological, laparoscopic, and robotic urology. He has over 25 years of clinical experience. Dr. Yossefovitz earned his MD at Jerusalem University. He also completed advanced fellowships at Memorial Sloan Kettering Cancer Center in the USA.
Dr. Yossefovitz has led oncological urology departments at Ichilov and Beilinson hospitals. He has published many scientific papers. He is also a Senior Lecturer at Tel Aviv University. Dr. Yossefovitz is a member of the Israeli, European, and American Urology Associations. His memberships reflect his international accreditation and recognition.
Professor Roksana Klepper is an experienced pediatric oncologist and nephrologist with 29 years of experience specializing in Children's Oncology and Diagnostics. She is proficient in English and Hebrew and is a member of several organizations related to Pediatrics, Nephrology and Renal Hypertension. She also prepares children for liver transplantation and has a Medical Center named after her.
Dr. Irina Stepfansky is an oncologist and internal medicine specialist at Sourasky Medical Center. She has more than 25 years of clinical experience. Since 2015, she has directed the Oncology Hospitalization department. Dr. Stepfansky earned her medical degree from Grodno University in Belarus. She completed advanced oncology training at Tel Aviv Medical Center.
Dr. Stepfansky has been licensed in Israel since 2000. She has led and participated in many phase I-III oncology clinical trials. Her work has helped improve cancer care and patient outcomes. She is recognized for her expertise in both internal medicine and oncology. Dr. Stepfansky has a strong record in research and clinical leadership.